Search by Drug Name or NDC

    NDC 00006-3856-02 RECARBRIO 500; 500; 250 mg/100mL; mg/100mL; mg/100mL Details

    RECARBRIO 500; 500; 250 mg/100mL; mg/100mL; mg/100mL

    RECARBRIO is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS.

    Product Information

    NDC 00006-3856
    Product ID 0006-3856_8a65f15d-ca70-46ce-b575-7a1b5092a243
    Associated GPIs 16159903402120
    GCN Sequence Number 080066
    GCN Sequence Number Description imipenem/cilastatin/relebactam VIAL 1.25 G INTRAVEN
    HIC3 W1S
    HIC3 Description CARBAPENEM ANTIBIOTICS (THIENAMYCINS)
    GCN 46743
    HICL Sequence Number 045883
    HICL Sequence Number Description IMIPENEM/CILASTATIN SODIUM/RELEBACTAM
    Brand/Generic Brand
    Proprietary Name RECARBRIO
    Proprietary Name Suffix n/a
    Non-Proprietary Name imipenem anhydrous, cilastatin, and relebactam anhydrous
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500; 500; 250
    Active Ingredient Units mg/100mL; mg/100mL; mg/100mL
    Substance Name CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212819
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-3856-02 (00006385602)

    NDC Package Code 0006-3856-02
    Billing NDC 00006385602
    Package 25 VIAL, SINGLE-DOSE in 1 CARTON (0006-3856-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01)
    Marketing Start Date 2020-01-06
    NDC Exclude Flag N
    Pricing Information N/A